Ligand Snaps Up Pfenex For Half A Billion

Value Of Transaction Could Top $500m Depending On Regulatory Milestone

Ligand Pharmaceuticals has struck a deal to acquire Pfenex in a transaction valued at up to $516m.

MnA
Ligand has struck a deal to acquire Pfenex • Source: Shutterstock

Pfenex is to be acquired by Ligand Pharmaceuticals in a deal that is valued at up to $516m, the companies have announced.

Ligand has signed a definitive agreement to acquire all outstanding shares of Pfenex for $12.00 per share in cash, or...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business